Venture Debt for SaaS: Who Qualifies and What It Really Costs

Venture debt is a term loan raised alongside an equity round — priced with interest plus warrants and a final payment. Here is who actually qualifies, how to price the warrants honestly, and what a bootstrapped SaaS company can raise instead.

Updated daily

$31M New Capital Committed This Month (August 2026)

743

SaaS companies funded since 2021

$271M

deployed to founders

What Is Venture Debt?

A term loan raised alongside an equity round — priced with interest, warrants, and a final payment

Venture debt is a term loan made to a venture-backed company, usually shortly after it closes an equity round. The lender is not underwriting your assets or your profitability — it is underwriting your investors. The implicit bet is that the fund that just led your round will lead or support the next one, and that this is what will repay the loan.

That is why the pricing looks unlike any other loan. You pay interest, and on top of it the lender takes warrants — the right to buy your stock at the last round’s price — plus a final payment at maturity. The headline interest rate is not the cost of venture debt. The cost is interest plus warrants plus the final payment plus whatever the covenants constrain you from doing.

Used well, it is a genuinely good instrument: it buys 6–12 months of runway between rounds without repricing the company, and for a fast-growing VC-backed company that is often cheaper than selling more equity at today’s valuation. Used badly — to paper over a round that is not coming — it adds a fixed monthly payment and a lien to a company that already has a problem.

Can You Actually Get Venture Debt?

For most bootstrapped SaaS founders reading this, the honest answer is no — and not because of your numbers. Nearly every venture-debt lender requires an institutional equity round with a named lead investor, because the investor is the collateral. You can be profitable, growing, and retaining customers better than the average VC-backed startup and still fail that test on the first question.

You can probably raise venture debt if

  • You have raised an institutional equity round (typically Series A or later) with a named lead investor

  • That investor is a recognised fund the lender already knows and expects to support the next round

  • You have 9–18 months of runway left — venture debt extends a runway, it does not rescue one

  • You can carry a fixed monthly payment through the whole term, including a bad quarter

  • You accept a lien on company assets, reporting covenants, and warrants on top of interest

You probably cannot if

  • Bootstrapped, profitable, or revenue-funded with no institutional round — most lenders stop here

  • Angel- or SAFE-funded only, with no priced round and no named lead

  • Raising for the first time — venture debt follows equity, it rarely leads it

  • Unwilling to issue warrants or accept covenants and a lien on the business

  • Below the lender’s revenue or round-size floor, which is usually far above $10K MRR

If you are bootstrapped, here is what you can get instead

Capital underwritten on your recurring revenue rather than on your investors. Revenue based financing and recurring revenue financing price your MRR, growth, retention, and margins — no round, no lead investor, no warrants. Founderpath funds from $10K MRR, returns an offer in about 24 hours after you connect your billing and bank data, and takes no equity, no board seat, and no warrants. The trade-off is real and worth naming: this is growth capital sized to the revenue you already have, not a runway bridge sized to the round you are hoping to raise.

What Venture Debt Actually Costs

Six things price a venture-debt facility. Only the first one shows up in the headline.

Interest

Usually floating — a base rate such as prime plus a spread. Across the market this has commonly landed in the high single digits to the mid teens, and it moves with the base rate over the life of the facility. This is the part founders compare, and it is the smallest part of the story.

Warrants

The lender takes the right to buy equity at the price of your last round. Coverage is quoted as a percentage of the facility — 10% warrant coverage on a $2M facility means $200K of stock at the last round price. This is real dilution, and it is worth more to the lender the better you do.

Final payment

A balloon or end-of-term fee, commonly quoted as a few percent of the principal, due when the facility matures. It is easy to miss in a term sheet because it does not appear in the monthly payment.

Fees and the draw period

Commitment or facility fees, legal costs, and a limited window to draw the money. Undrawn capital can still cost you, and an unused facility can expire.

Covenants and the lien

A UCC-1 lien on company assets, reporting obligations, sometimes minimum cash or revenue covenants, and a material-adverse-change clause. Breaching a covenant can accelerate the whole loan — usually at the exact moment you can least afford it.

Amortisation shape

Typically an interest-only period followed by principal-plus-interest over the remaining term. The interest-only window is what makes the early months feel cheap; the amortising months are what you have to survive.

A Worked Example: What a $2M Facility Really Costs

An illustration, not a quote. Terms are bespoke to each deal and each lender, so treat these as plausible mid-market assumptions rather than a market average: a $2,000,000 facility, 12% interest, a 36-month term with the first 12 months interest-only, a 3% final payment, and 10% warrant coverage.

  • Interest, 12 months interest-only: about $240,000

  • Interest, 24 months amortising down to zero: about $245,000

  • Final payment at maturity, 3% of principal: $60,000

  • Cash cost before warrants: about $545,000

  • Warrants, 10% coverage: $200,000 of stock at your last round’s price

So a facility that was pitched at “12%” costs roughly $545,000 in cash on $2M — and hands over $200,000 of equity at a price that only looks cheap in hindsight. If the company triples before the warrants are exercised, that $200,000 slice is worth far more than the interest ever was. That is the part worth modelling before you sign, and you can put a number on it with the free dilution calculator and the runway calculator.

Venture Debt vs Revenue Based Financing

These are the two structures founders most often weigh against each other, and they are underwritten on opposite things. Venture debt prices your investors. Revenue based financing prices your revenue. That single difference drives every row below.

Factor

Venture Debt

Revenue Based Financing

Who qualifies

VC-backed companies with a priced round and a named lead investor

Any B2B SaaS company with recurring revenue — Founderpath starts at $10K MRR, no investors required

Equity attached

Warrants, quoted as a percentage of the facility — real dilution on top of interest

None. No warrants, no equity, no board seats

What it is priced on

Your investors, your last round, and your runway

Your recurring revenue — MRR, growth, churn, and gross margin

Cost structure

Floating interest + warrants + a final payment + fees

A fixed discount rate from 7%, or interest from 15% on a term loan — disclosed in full before you accept

Covenants

Reporting covenants, a lien on company assets, sometimes minimum cash or revenue tests

No financial covenants and no personal guarantee

Speed to money

Weeks — diligence, sponsor calls, and legal documentation

An offer in about 24 hours after you connect billing and banking data

If you miss a month

A covenant breach can accelerate the facility and put the lien in play

Fixed monthly payments with no covenant to trip; you work it out with the lender

What it is for

Extending runway between equity rounds without repricing the company

Funding growth — hiring, marketing, inventory — out of revenue you already have

Neither is strictly better. If you are VC-backed, mid-round, and need to reach a milestone before your next raise, venture debt is usually the cheaper way to buy that time. If you are bootstrapped and growing on your own revenue, revenue based financing is the one you can actually get — and it does not cost you equity. You can compare the whole non-dilutive market in the revenue based financing companies roundup.

Venture Debt vs Venture Capital

Venture debt is often sold as the non-dilutive alternative to another equity round. It is less dilutive, not non-dilutive. A priced round typically sells 15–30% of the company; warrant coverage on a facility sells a far smaller slice. But warrants are still equity, and the honest way to compare the two is to convert the warrants into a percentage of the cap table and put it next to the round you would otherwise raise.

The second difference is control. Venture capital brings board seats, information rights, and an expectation about the shape of your outcome. Venture debt brings covenants and a lien instead — fewer opinions about strategy, more constraints on the balance sheet. If you are weighing an equity round at all, the venture capital guide walks through what you give up, and non-dilutive funding covers what is available if you would rather not.

Who Lends Venture Debt

Three kinds of lender, with genuinely different behaviour:

  • Banks with venture practices. The cheapest headline rates, the tightest covenants, and usually a requirement to move your operating accounts across. Diligence is the slowest of the three.

  • Specialist venture-debt funds. More expensive than banks and more flexible on structure. They price for the equity upside, so warrant coverage matters more here than the coupon does.

  • Fintech and revenue-based lenders. Faster and lighter on process, and the group most likely to lend without a VC round — but at that point you are usually looking at revenue-underwritten capital rather than venture debt proper.

Whichever you talk to, ask for the same four numbers before you compare anything: the interest rate, the warrant coverage, the final payment, and every covenant in the document. Two facilities with the same coupon can differ enormously once those are on the table. For a side-by-side against a specific bank venture-debt programme, see Founderpath vs SVB.

What Founderpath Does Instead

Founderpath does not offer venture debt, and does not require you to have raised one. It funds bootstrapped SaaS companies against their recurring revenue: qualify from $10K MRR, get an offer in about 24 hours after connecting your billing and banking data, and keep 100% of your equity — no warrants, no board seats, no personal guarantee, no financial covenants, and no closing costs.

Two structures: Revenue Financing at a 7% discount rate over 12–36 months for companies from $10K MRR, and Term Loans from 15% interest over up to 48 months for companies above $3M ARR, with interest-only payments for up to the first 24. Both use fixed monthly payments and disclose the full cost before you accept.

Find Your Best Financing Option

Answer 3 quick questions to get a personalized recommendation.

Question 1 of 3

What's your annual recurring revenue (ARR)?

Frequently Asked Questions

Usually not. Nearly every venture-debt lender requires an institutional equity round with a named lead investor, because the investor — not your revenue — is what the loan is really underwritten against. You can be profitable, growing, and retaining customers better than the average VC-backed startup and still fail that first question.

What a bootstrapped company can raise is capital underwritten on its recurring revenue: revenue based financing or a term loan priced on MRR, growth, retention, and margins. Founderpath funds from $10K MRR with an offer in about 24 hours, and takes no equity, no warrants, and no board seat.
For traditional venture debt, effectively yes. Lenders want a priced round with a recognised lead investor they expect to support the next round — that expectation is the collateral. Angel money, SAFEs, or a strong revenue history on their own generally will not clear the bar.

Some fintech and revenue-based lenders will lend without a round, but at that point the product is no longer venture debt: it is capital underwritten on your revenue, with different pricing and no warrants.
Warrant coverage is quoted as a percentage of the facility. 10% coverage on a $2M facility means the lender can buy $200,000 of stock at the price of your last round. Coverage is negotiated per deal and generally trades off against the interest rate — cheaper coupon, more warrants.

Warrants are the part founders under-price. They cost nothing today and a great deal if the company appreciates, because the strike is fixed at a valuation you have already outgrown. Convert the coverage into a percentage of your cap table with the dilution calculator before you compare two term sheets.
Venture-debt pricing is usually floating — a base rate such as prime plus a spread — so it moves over the life of the facility. Across the market it has commonly sat in the high single digits to the mid teens, but the range is wide and every deal is negotiated separately.

The rate is also the least informative number in the term sheet. Ask for all four: the interest rate, the warrant coverage, the final payment, and the covenants. Two facilities quoted at the same rate can differ by hundreds of thousands of dollars once the warrants and the balloon payment are counted.
On cash cost alone, venture debt often looks cheaper, because its coupon is lower. Once you add the warrants and the final payment, the comparison usually narrows and can reverse — especially for a company that grows a lot during the term, since the warrants are worth more the better you do.

The more useful question is which one you can actually get. Venture debt requires a VC round; revenue based financing requires recurring revenue. For a bootstrapped SaaS company there is often only one of these on the table, and it is the one that takes no equity.
The constraint is the monthly payment, not the headline amount. A facility is safe to the extent you can service it out of cash flow through a bad quarter — after the interest-only period ends and principal starts amortising, which is when most companies feel it.

Two practical tests before you sign: model the payment in the worst month you can plausibly have, and check that the facility genuinely reaches a milestone that makes the next round easier to raise. Borrowing to survive rather than to reach a milestone is what turns venture debt into a problem. The runway calculator is a reasonable place to start.

Non-Dilutive Capital for SaaS Founders — Funded in 24 Hours

Founderpath has deployed $271M to 743 bootstrapped SaaS founders. Connect your data, get a fixed funding offer, keep all your equity.

What Founderpath financing includes

  • No equity — keep 100% of your company

  • No board seats, no warrants, no covenants

  • Funding offer in 24 hours after connecting data

  • Fixed monthly payments — no revenue percentage

  • No closing costs or origination fees

  • Minimum $10K MRR — worldwide eligible